VEGFR2/CD309 Antikörper
Kurzübersicht für VEGFR2/CD309 Antikörper (ABIN2141992)
Target
Alle VEGFR2/CD309 (VEGFR2) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Aufreinigung
- Purified by affinity chromatography.
-
Isotyp
- IgG2a kappa
-
-
-
-
Applikationshinweise
-
FC: ≤ 1 μg/test
Optimal working dilution should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- In aqueous buffer with 0.09 % sodium azide, may contain carrier prote/stabilizer.
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze/thaw cycles
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8 °C. Do not freeze. Protect from light
-
-
-
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." in: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
: "VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis." in: Developmental cell, Vol. 18, Issue 5, pp. 713-24, (2010) (PubMed).
: "
-
The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis." in: Developmental cell, Vol. 25, Issue 2, pp. 156-68, (2013) (PubMed).
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Andere Bezeichnung
- Flk1
-
Pathways
- RTK Signalweg, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-